LRP1 and central nervous system cancer: These innovative nanocarriers have demonstrated the ability to transport paclitaxel (PTX) through the BBB, facilitated by the low-density lipoprotein receptor-related protein 1 (LRP1), thus showing great potential for treating gliomas [71].